This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Hospitalier Régional Et Universitaire De Brest, Établisssement Français Du Sang, National Institute of Health and Medical Research. Active years: 2012-2025.
Company Filing History:
1 out of 12 
1 out of 1 
1 out of 1,853 
Years Active: 2012-2025
Title: The Innovative Contributions of Serge Timsit
Introduction
Serge Timsit is a notable inventor based in Brest, France. He has made significant contributions to the field of medical diagnostics and treatment, particularly in relation to neurological diseases. With a total of 2 patents, Timsit has developed innovative methods that aim to improve patient outcomes.
Latest Patents
One of Timsit's latest patents focuses on blood biomarkers of stroke. This invention provides a method for diagnosing a stroke, determining whether a subject suffering from a stroke will respond to therapy, assessing the risk of stroke in a subject, and treating a stroke by analyzing biomarkers such as PTGS2, HMOX1, and others. Another significant patent involves the administration of (S)-roscovitine for the protection against and treatment of neurological diseases. This invention relates to the use of a specific compound for manufacturing medication aimed at preventing or treating neurological conditions associated with lesions.
Career Highlights
Throughout his career, Serge Timsit has worked with esteemed institutions such as Université De Bretagne Occidentale and Neurokin. His work in these organizations has allowed him to further his research and develop his innovative ideas.
Collaborations
Timsit has collaborated with notable individuals in his field, including Bénédicte Menn and Laurent Meijer. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Serge Timsit is a distinguished inventor whose work has the potential to significantly impact the diagnosis and treatment of neurological diseases. His innovative patents reflect his commitment to advancing medical science and improving patient care.